chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: PPV
Symptoms: Nerve injury
Clinical narrative: This spontaneous report as received from a pharmacist refers to a female patient of unknown age. The patient was vaccinated with one dose of 0.5 ml PNEUMOVAX23 (lot number, route not reported) on an unknown date. No other co-suspects were reported. No concomitant medications were reported. The pharmacist reported that they administered the PNEUMOVAX23 to the patient and "they must have hit a nerve or something" because the patient developed "nerve damage and had to get physical therapy in her arm." The patient had sought unspecified medical attention. It was also reported that the patient experienced "something similar" with another unspecified vaccine when she was younger. Additional information has been requested.
Age: 55.0
Sex: F
Vaccine: VARZOS
Symptoms: Tenderness
Clinical narrative: This spontaneous report as received from a registered nurse refers to herself a 55 years old female patient with no drug reaction or allergies, and no pertinent medical history. The patient was vaccinated intramuscularly with a dose of ZOSTAVAX (Lot # and dose not reported) on 18-OCT-2012. There were no concomitant medications. The next day on 19-OCT-2012 the patient experienced a little tenderness which lasted about 2-3 days. The patient did not seek for medical attention. No treatment information was given. No lab diagnostic studies were performed. On approximately 22-OCT-2012 patient recovered. This is one of several reports received from a same reporter. Additional information has been requested.
Age: 65.0
Sex: F
Vaccine: PPV, FLUX, PPV
Symptoms: Injection site cellulitis, Injection site pain, Injection site swelling
Clinical narrative: This medically confirmed spontaneous report (initial receipt: 18-Oct-2012) concerns a 65-year-old female patient, who had a pertinent medical history of diabetes and unspecified cardiac issues. She had allergy to penicillin. On 11-Oct-2012 the patient was hospitalised for an unrelated cardiac health issue. On 11-Oct-2012, the same day the patient was hospitalised, the patient received a flu vaccine (manufacturer, brand name and batch number were not provided) in right arm. On the same day she also received PNEUMOVAX 23 (batch number was not provided) injection at a dose of 0.5 mL in left arm for vaccination. The patient developed a sore, swollen, tender and cellulitis of the left arm where PNEUMOVAX 23 was administered. The nurse (reporter) was not sure if PNEUMOVAX 23 was administered below the deltoid site or not. She stated the patient was chubby, and has odd shaped arms and it was hard to define where the deltoid area was. The patient also developed a reaction of the right arm, less than 2 inches around hematoma on the right arm, where the unspecified flu vaccine was administered. The nurse believed that the patient's hospitalisation may have been prolonged because of the adverse reaction to the vaccines. The patient was treated with unspecified antibiotics and was discharged from hospital on 15-Oct-2012. On 25-Oct-2012 the nurse spoke with the patient via a telephone conversation. The patient stated that her left arm was still tender and she reported having some finger numbness. The patient stated that she would follow up with her PCP (primary care physician). On 29-Oct-2012, the patient's cardiologist confirmed this. Follow up (07-Nov-2012): additional AE term, patient's current condition.
Age: 65.0
Sex: F
Vaccine: PPV, FLUX, PPV
Symptoms: Hypoaesthesia, Injection site cellulitis, Injection site haematoma, Injection site pain, Injection site swelling
Clinical narrative: This medically confirmed spontaneous report (initial receipt: 18-Oct-2012) concerns a 65-year-old female patient, who had a pertinent medical history of diabetes and unspecified cardiac issues. She had allergy to penicillin. On 11-Oct-2012 the patient was hospitalised for an unrelated cardiac health issue. On 11-Oct-2012, the same day the patient was hospitalised, the patient received a flu vaccine (manufacturer, brand name and batch number were not provided) in right arm. On the same day she also received PNEUMOVAX 23 (batch number was not provided) injection at a dose of 0.5 mL in left arm for vaccination. The patient developed a sore, swollen, tender and cellulitis of the left arm where PNEUMOVAX 23 was administered. The nurse (reporter) was not sure if PNEUMOVAX 23 was administered below the deltoid site or not. She stated the patient was chubby, and has odd shaped arms and it was hard to define where the deltoid area was. The patient also developed a reaction of the right arm, less than 2 inches around hematoma on the right arm, where the unspecified flu vaccine was administered. The nurse believed that the patient's hospitalisation may have been prolonged because of the adverse reaction to the vaccines. The patient was treated with unspecified antibiotics and was discharged from hospital on 15-Oct-2012. On 25-Oct-2012 the nurse spoke with the patient via a telephone conversation. The patient stated that her left arm was still tender and she reported having some finger numbness. The patient stated that she would follow up with her PCP (primary care physician). On 29-Oct-2012, the patient's cardiologist confirmed this. Follow up (07-Nov-2012): additional AE term, patient's current condition.
Age: 56.0
Sex: M
Vaccine: HEPAB, PPV, HEPAB
Symptoms: Condition aggravated, Diarrhoea, Motor dysfunction, Muscle spasms, Nausea
Clinical narrative: This case was reported by a consumer and described the occurrence of paralysis of shoulder in a 56-year-old male subject who was vaccinated with TWINRIX (GlaxoSmithKline). A physician or other health care professional has not verified this report. Concurrent medical conditions included celiac disease, diarrhea, human immunodeficiency virus, lactose intolerance, prostate problem, shellfish allergy, testicular cyst, testicular hydrocele and testicular pain. Concurrent medications included ISENTRESS, PREZISTA, NORVIR, TRUVADA, LOMOTIL, Finasteride, BACTRIM, Hydrocodone and Estradiol. On 16 August 2012 at 16:50 the subject received unspecified dose of TWINRIX (unknown, left arm). On 16 August 2012 at 17:10, 20 minutes after vaccination with TWINRIX, the subject experienced stomach cramps and stomach pressure. On 16 August 2012 at 17:30, 40 minutes after vaccination with TWINRIX, the subject experienced "extreme" diarrhea. The subject indicated that he had problems with diarrhea prior to the vaccination, but believed the vaccination exacerbated it. On 19 August 2012, 3 days after vaccination with TWINRIX, the subject experienced worsening testicular pain at 12:00, disorientation, irrational and bloating. The subject reported that he had testicular pain prior to the vaccination, but felt the vaccination exacerbated the problem. On 23 or 24 August 2012, 7 to 8 days after vaccination with TWINRIX, the subject experienced paralysis of "upper" shoulders, paralysis arms, spinal cord paralysis. On 03 September 2012, 18 days after vaccination with TWINRIX, the subject experienced decreased mobility of leg described as "unable to move his legs normally and and had difficulty jogging" and loss of motor control. On 22 September 2011, 36 days after vaccination with TWINRIX, the subject experienced fell down stairs and assaulted ("beat up by thugs"). On an unknown date in 2012, the subject experienced eye-light sensitivity, sound sensitivity and unable to go out. This case was assessed as medically serious by GSK. At the time of reporting the eye-light sensitivity, sound sensitivity and unable to go out were unresolved; the worsening testicular pain was improved; and the outcome of the other events was unknown. The vaccination course with TWINRIX was discontinued.
Age: 56.0
Sex: M
Vaccine: HEPAB, PPV, HEPAB
Symptoms: Pain, Paralysis, Pyrexia, Testicular disorder, Ultrasound testes abnormal
Clinical narrative: This case was reported by a consumer and described the occurrence of paralysis of shoulder in a 56-year-old male subject who was vaccinated with TWINRIX (GlaxoSmithKline). A physician or other health care professional has not verified this report. Concurrent medical conditions included celiac disease, diarrhea, human immunodeficiency virus, lactose intolerance, prostate problem, shellfish allergy, testicular cyst, testicular hydrocele and testicular pain. Concurrent medications included ISENTRESS, PREZISTA, NORVIR, TRUVADA, LOMOTIL, Finasteride, BACTRIM, Hydrocodone and Estradiol. On 16 August 2012 at 16:50 the subject received unspecified dose of TWINRIX (unknown, left arm). On 16 August 2012 at 17:10, 20 minutes after vaccination with TWINRIX, the subject experienced stomach cramps and stomach pressure. On 16 August 2012 at 17:30, 40 minutes after vaccination with TWINRIX, the subject experienced "extreme" diarrhea. The subject indicated that he had problems with diarrhea prior to the vaccination, but believed the vaccination exacerbated it. On 19 August 2012, 3 days after vaccination with TWINRIX, the subject experienced worsening testicular pain at 12:00, disorientation, irrational and bloating. The subject reported that he had testicular pain prior to the vaccination, but felt the vaccination exacerbated the problem. On 23 or 24 August 2012, 7 to 8 days after vaccination with TWINRIX, the subject experienced paralysis of "upper" shoulders, paralysis arms, spinal cord paralysis. On 03 September 2012, 18 days after vaccination with TWINRIX, the subject experienced decreased mobility of leg described as "unable to move his legs normally and and had difficulty jogging" and loss of motor control. On 22 September 2011, 36 days after vaccination with TWINRIX, the subject experienced fell down stairs and assaulted ("beat up by thugs"). On an unknown date in 2012, the subject experienced eye-light sensitivity, sound sensitivity and unable to go out. This case was assessed as medically serious by GSK. At the time of reporting the eye-light sensitivity, sound sensitivity and unable to go out were unresolved; the worsening testicular pain was improved; and the outcome of the other events was unknown. The vaccination course with TWINRIX was discontinued.
Age: 56.0
Sex: M
Vaccine: HEPAB, PPV, HEPAB
Symptoms: Abdominal discomfort, Abdominal distension, Abdominal pain upper, Activities of daily living impaired, Condition aggravated
Clinical narrative: This case was reported by a consumer and described the occurrence of paralysis of shoulder in a 56-year-old male subject who was vaccinated with TWINRIX (GlaxoSmithKline). A physician or other health care professional has not verified this report. Concurrent medical conditions included celiac disease, diarrhea, human immunodeficiency virus, lactose intolerance, prostate problem, shellfish allergy, testicular cyst, testicular hydrocele and testicular pain. Concurrent medications included ISENTRESS, PREZISTA, NORVIR, TRUVADA, LOMOTIL, Finasteride, BACTRIM, Hydrocodone and Estradiol. On 16 August 2012 at 16:50 the subject received unspecified dose of TWINRIX (unknown, left arm). On 16 August 2012 at 17:10, 20 minutes after vaccination with TWINRIX, the subject experienced stomach cramps and stomach pressure. On 16 August 2012 at 17:30, 40 minutes after vaccination with TWINRIX, the subject experienced "extreme" diarrhea. The subject indicated that he had problems with diarrhea prior to the vaccination, but believed the vaccination exacerbated it. On 19 August 2012, 3 days after vaccination with TWINRIX, the subject experienced worsening testicular pain at 12:00, disorientation, irrational and bloating. The subject reported that he had testicular pain prior to the vaccination, but felt the vaccination exacerbated the problem. On 23 or 24 August 2012, 7 to 8 days after vaccination with TWINRIX, the subject experienced paralysis of "upper" shoulders, paralysis arms, spinal cord paralysis. On 03 September 2012, 18 days after vaccination with TWINRIX, the subject experienced decreased mobility of leg described as "unable to move his legs normally and and had difficulty jogging" and loss of motor control. On 22 September 2011, 36 days after vaccination with TWINRIX, the subject experienced fell down stairs and assaulted ("beat up by thugs"). On an unknown date in 2012, the subject experienced eye-light sensitivity, sound sensitivity and unable to go out. This case was assessed as medically serious by GSK. At the time of reporting the eye-light sensitivity, sound sensitivity and unable to go out were unresolved; the worsening testicular pain was improved; and the outcome of the other events was unknown. The vaccination course with TWINRIX was discontinued.
Age: 56.0
Sex: M
Vaccine: HEPAB, PPV, HEPAB
Symptoms: Diarrhoea, Diplegia, Disorientation, Fall, Hyperacusis
Clinical narrative: This case was reported by a consumer and described the occurrence of paralysis of shoulder in a 56-year-old male subject who was vaccinated with TWINRIX (GlaxoSmithKline). A physician or other health care professional has not verified this report. Concurrent medical conditions included celiac disease, diarrhea, human immunodeficiency virus, lactose intolerance, prostate problem, shellfish allergy, testicular cyst, testicular hydrocele and testicular pain. Concurrent medications included ISENTRESS, PREZISTA, NORVIR, TRUVADA, LOMOTIL, Finasteride, BACTRIM, Hydrocodone and Estradiol. On 16 August 2012 at 16:50 the subject received unspecified dose of TWINRIX (unknown, left arm). On 16 August 2012 at 17:10, 20 minutes after vaccination with TWINRIX, the subject experienced stomach cramps and stomach pressure. On 16 August 2012 at 17:30, 40 minutes after vaccination with TWINRIX, the subject experienced "extreme" diarrhea. The subject indicated that he had problems with diarrhea prior to the vaccination, but believed the vaccination exacerbated it. On 19 August 2012, 3 days after vaccination with TWINRIX, the subject experienced worsening testicular pain at 12:00, disorientation, irrational and bloating. The subject reported that he had testicular pain prior to the vaccination, but felt the vaccination exacerbated the problem. On 23 or 24 August 2012, 7 to 8 days after vaccination with TWINRIX, the subject experienced paralysis of "upper" shoulders, paralysis arms, spinal cord paralysis. On 03 September 2012, 18 days after vaccination with TWINRIX, the subject experienced decreased mobility of leg described as "unable to move his legs normally and and had difficulty jogging" and loss of motor control. On 22 September 2011, 36 days after vaccination with TWINRIX, the subject experienced fell down stairs and assaulted ("beat up by thugs"). On an unknown date in 2012, the subject experienced eye-light sensitivity, sound sensitivity and unable to go out. This case was assessed as medically serious by GSK. At the time of reporting the eye-light sensitivity, sound sensitivity and unable to go out were unresolved; the worsening testicular pain was improved; and the outcome of the other events was unknown. The vaccination course with TWINRIX was discontinued.
Age: 56.0
Sex: M
Vaccine: HEPAB, PPV, HEPAB
Symptoms: Mobility decreased, Motor dysfunction, Photophobia, Spinal cord paralysis, Testicular pain
Clinical narrative: This case was reported by a consumer and described the occurrence of paralysis of shoulder in a 56-year-old male subject who was vaccinated with TWINRIX (GlaxoSmithKline). A physician or other health care professional has not verified this report. Concurrent medical conditions included celiac disease, diarrhea, human immunodeficiency virus, lactose intolerance, prostate problem, shellfish allergy, testicular cyst, testicular hydrocele and testicular pain. Concurrent medications included ISENTRESS, PREZISTA, NORVIR, TRUVADA, LOMOTIL, Finasteride, BACTRIM, Hydrocodone and Estradiol. On 16 August 2012 at 16:50 the subject received unspecified dose of TWINRIX (unknown, left arm). On 16 August 2012 at 17:10, 20 minutes after vaccination with TWINRIX, the subject experienced stomach cramps and stomach pressure. On 16 August 2012 at 17:30, 40 minutes after vaccination with TWINRIX, the subject experienced "extreme" diarrhea. The subject indicated that he had problems with diarrhea prior to the vaccination, but believed the vaccination exacerbated it. On 19 August 2012, 3 days after vaccination with TWINRIX, the subject experienced worsening testicular pain at 12:00, disorientation, irrational and bloating. The subject reported that he had testicular pain prior to the vaccination, but felt the vaccination exacerbated the problem. On 23 or 24 August 2012, 7 to 8 days after vaccination with TWINRIX, the subject experienced paralysis of "upper" shoulders, paralysis arms, spinal cord paralysis. On 03 September 2012, 18 days after vaccination with TWINRIX, the subject experienced decreased mobility of leg described as "unable to move his legs normally and and had difficulty jogging" and loss of motor control. On 22 September 2011, 36 days after vaccination with TWINRIX, the subject experienced fell down stairs and assaulted ("beat up by thugs"). On an unknown date in 2012, the subject experienced eye-light sensitivity, sound sensitivity and unable to go out. This case was assessed as medically serious by GSK. At the time of reporting the eye-light sensitivity, sound sensitivity and unable to go out were unresolved; the worsening testicular pain was improved; and the outcome of the other events was unknown. The vaccination course with TWINRIX was discontinued.
Age: 56.0
Sex: M
Vaccine: HEPAB, PPV, HEPAB
Symptoms: Thinking abnormal, Victim of crime
Clinical narrative: This case was reported by a consumer and described the occurrence of paralysis of shoulder in a 56-year-old male subject who was vaccinated with TWINRIX (GlaxoSmithKline). A physician or other health care professional has not verified this report. Concurrent medical conditions included celiac disease, diarrhea, human immunodeficiency virus, lactose intolerance, prostate problem, shellfish allergy, testicular cyst, testicular hydrocele and testicular pain. Concurrent medications included ISENTRESS, PREZISTA, NORVIR, TRUVADA, LOMOTIL, Finasteride, BACTRIM, Hydrocodone and Estradiol. On 16 August 2012 at 16:50 the subject received unspecified dose of TWINRIX (unknown, left arm). On 16 August 2012 at 17:10, 20 minutes after vaccination with TWINRIX, the subject experienced stomach cramps and stomach pressure. On 16 August 2012 at 17:30, 40 minutes after vaccination with TWINRIX, the subject experienced "extreme" diarrhea. The subject indicated that he had problems with diarrhea prior to the vaccination, but believed the vaccination exacerbated it. On 19 August 2012, 3 days after vaccination with TWINRIX, the subject experienced worsening testicular pain at 12:00, disorientation, irrational and bloating. The subject reported that he had testicular pain prior to the vaccination, but felt the vaccination exacerbated the problem. On 23 or 24 August 2012, 7 to 8 days after vaccination with TWINRIX, the subject experienced paralysis of "upper" shoulders, paralysis arms, spinal cord paralysis. On 03 September 2012, 18 days after vaccination with TWINRIX, the subject experienced decreased mobility of leg described as "unable to move his legs normally and and had difficulty jogging" and loss of motor control. On 22 September 2011, 36 days after vaccination with TWINRIX, the subject experienced fell down stairs and assaulted ("beat up by thugs"). On an unknown date in 2012, the subject experienced eye-light sensitivity, sound sensitivity and unable to go out. This case was assessed as medically serious by GSK. At the time of reporting the eye-light sensitivity, sound sensitivity and unable to go out were unresolved; the worsening testicular pain was improved; and the outcome of the other events was unknown. The vaccination course with TWINRIX was discontinued.
Age: 42.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Aphasia, Chest X-ray normal, Computerised tomogram head, Computerised tomogram normal, Diarrhoea
Clinical narrative: Initial report was received on 08 November 2012 from a consumer, who is also the patient. A 42-year-old female patient had received an intramuscular injection of FLUZONE, lot number UH759AA (site not reported) on 01 November 2012 and on the evening of vaccination, she developed diarrhea for 1.5 hours. On 03 November 2012, she "felt like eyes were stuck, vision far away" for a few minutes, and developed aphasia for 45 minutes. She went to the emergency room and was admitted to the hospital for three days. The patient had been seen by a neurologist. Diagnostic testing included a MRI and CT head (results not reported). The patient has since had a headache, "feels foggy, cognitive is off", has fatigue and neck pain. She was evaluated by her physician on 09 November 2012 and was to be evaluated by a MS specialist in the future to rule out MS. Outcome was not recovered. Documents held by sender: None.
Age: 42.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Echocardiogram normal, Electroencephalogram normal, Fatigue, Feeling abnormal, Headache
Clinical narrative: Initial report was received on 08 November 2012 from a consumer, who is also the patient. A 42-year-old female patient had received an intramuscular injection of FLUZONE, lot number UH759AA (site not reported) on 01 November 2012 and on the evening of vaccination, she developed diarrhea for 1.5 hours. On 03 November 2012, she "felt like eyes were stuck, vision far away" for a few minutes, and developed aphasia for 45 minutes. She went to the emergency room and was admitted to the hospital for three days. The patient had been seen by a neurologist. Diagnostic testing included a MRI and CT head (results not reported). The patient has since had a headache, "feels foggy, cognitive is off", has fatigue and neck pain. She was evaluated by her physician on 09 November 2012 and was to be evaluated by a MS specialist in the future to rule out MS. Outcome was not recovered. Documents held by sender: None.
Age: 42.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Laboratory test normal, Nuclear magnetic resonance imaging normal, Speech disorder, Transient ischaemic attack, Ultrasound Doppler
Clinical narrative: Initial report was received on 08 November 2012 from a consumer, who is also the patient. A 42-year-old female patient had received an intramuscular injection of FLUZONE, lot number UH759AA (site not reported) on 01 November 2012 and on the evening of vaccination, she developed diarrhea for 1.5 hours. On 03 November 2012, she "felt like eyes were stuck, vision far away" for a few minutes, and developed aphasia for 45 minutes. She went to the emergency room and was admitted to the hospital for three days. The patient had been seen by a neurologist. Diagnostic testing included a MRI and CT head (results not reported). The patient has since had a headache, "feels foggy, cognitive is off", has fatigue and neck pain. She was evaluated by her physician on 09 November 2012 and was to be evaluated by a MS specialist in the future to rule out MS. Outcome was not recovered. Documents held by sender: None.
Age: 42.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Ultrasound Doppler normal, Visual impairment
Clinical narrative: Initial report was received on 08 November 2012 from a consumer, who is also the patient. A 42-year-old female patient had received an intramuscular injection of FLUZONE, lot number UH759AA (site not reported) on 01 November 2012 and on the evening of vaccination, she developed diarrhea for 1.5 hours. On 03 November 2012, she "felt like eyes were stuck, vision far away" for a few minutes, and developed aphasia for 45 minutes. She went to the emergency room and was admitted to the hospital for three days. The patient had been seen by a neurologist. Diagnostic testing included a MRI and CT head (results not reported). The patient has since had a headache, "feels foggy, cognitive is off", has fatigue and neck pain. She was evaluated by her physician on 09 November 2012 and was to be evaluated by a MS specialist in the future to rule out MS. Outcome was not recovered. Documents held by sender: None.
Age: 42.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Aphasia, Cognitive disorder, Computerised tomogram head, Diarrhoea, Fatigue
Clinical narrative: Initial report was received on 08 November 2012 from a consumer, who is also the patient. A 42-year-old female patient had received an intramuscular injection of FLUZONE, lot number UH759AA (site not reported) on 01 November 2012 and on the evening of vaccination, she developed diarrhea for 1.5 hours. On 03 November 2012, she "felt like eyes were stuck, vision far away" for a few minutes, and developed aphasia for 45 minutes. She went to the emergency room and was admitted to the hospital for three days. The patient had been seen by a neurologist. Diagnostic testing included a MRI and CT head (results not reported). The patient has since had a headache, "feels foggy, cognitive is off", has fatigue and neck pain. She was evaluated by her physician on 09 November 2012 and was to be evaluated by a MS specialist in the future to rule out MS. Outcome was not recovered. Documents held by sender: None.
Age: 42.0
Sex: F
Vaccine: FLU3, FLU3
Symptoms: Feeling abnormal, Headache, Neck pain, Nuclear magnetic resonance imaging, Visual impairment
Clinical narrative: Initial report was received on 08 November 2012 from a consumer, who is also the patient. A 42-year-old female patient had received an intramuscular injection of FLUZONE, lot number UH759AA (site not reported) on 01 November 2012 and on the evening of vaccination, she developed diarrhea for 1.5 hours. On 03 November 2012, she "felt like eyes were stuck, vision far away" for a few minutes, and developed aphasia for 45 minutes. She went to the emergency room and was admitted to the hospital for three days. The patient had been seen by a neurologist. Diagnostic testing included a MRI and CT head (results not reported). The patient has since had a headache, "feels foggy, cognitive is off", has fatigue and neck pain. She was evaluated by her physician on 09 November 2012 and was to be evaluated by a MS specialist in the future to rule out MS. Outcome was not recovered. Documents held by sender: None.
Age: 80.0
Sex: M
Vaccine: PPV, PPV
Symptoms: Burning sensation, Oedema peripheral, Rash, Rash erythematous
Clinical narrative: Patient stopped by today as a walk in c/o developed rash and swelling over left arm after getting pneumonia shot yesterday. Denies any difficulty breathing or sob. No itchiness over the rash, but feeling burns. O/E: Alert and oriented, not in distress VS: stable. Lungs: clear CVS: S1 S2 regular, Abdomen: benign. CNS: no focal deficit. Skin: erythematous rash noted over left arm. A/P: rash left arm, due to reaction to PNEUMOVAX. Will put on MEDROL dose pack and BENADRYL prn. Outpatient Pneumococcal vaccine ordered. Patient received 0.5 ml of pneumococcal vaccine IM at this encounter. Site: Lt deltoid. Manufacturer: Merck Lot #: 1427Y Exp. date: 7/3/11. Symptoms: Symptoms: 1. Angioedema, 2. Rash, 3. Paresthesia. Treatment Drugs Used: 1 - Methylprednisolone Dose: ud Units: TAB Freq: Every day Route: PO.
Age: 80.0
Sex: M
Vaccine: PPV, PPV
Symptoms: Burning sensation, Oedema peripheral, Rash, Rash erythematous, Vaccination complication
Clinical narrative: Patient stopped by today as a walk in c/o developed rash and swelling over left arm after getting pneumonia shot yesterday. Denies any difficulty breathing or sob. No itchiness over the rash, but feeling burns. O/E: Alert and oriented, not in distress VS: stable. Lungs: clear CVS: S1 S2 regular, Abdomen: benign. CNS: no focal deficit. Skin: erythematous rash noted over left arm. A/P: rash left arm, due to reaction to PNEUMOVAX. Will put on MEDROL dose pack and BENADRYL prn. Outpatient Pneumococcal vaccine ordered. Patient received 0.5 ml of pneumococcal vaccine IM at this encounter. Site: Lt deltoid. Manufacturer: Merck Lot #: 1427Y Exp. date: 7/3/11. Symptoms: Symptoms: 1. Angioedema, 2. Rash, 3. Paresthesia. Treatment Drugs Used: 1 - Methylprednisolone Dose: ud Units: TAB Freq: Every day Route: PO.
Age: 5.0
Sex: M
Vaccine: FLU3, FLUX
Symptoms: Asthma, Brain injury, Cognitive disorder, Condition aggravated, Electroencephalogram abnormal
Clinical narrative: Patient had gotten the flu shot on - Oct. 02-212. Next day running fever and had asthma attack went into respiratory failure and was brought back was air lifted to hospital and spent 17 days in hospital and suffered hypoxic brain injury due to lack of oxygen, during all of this.
Age: 5.0
Sex: M
Vaccine: FLU3, FLUX
Symptoms: Endotracheal intubation, Intensive care, Nuclear magnetic resonance imaging abnormal, Physical disability, Respiratory failure
Clinical narrative: Patient had gotten the flu shot on - Oct. 02-212. Next day running fever and had asthma attack went into respiratory failure and was brought back was air lifted to hospital and spent 17 days in hospital and suffered hypoxic brain injury due to lack of oxygen, during all of this.
Age: 5.0
Sex: M
Vaccine: FLU3, FLUX
Symptoms: Status asthmaticus, Weight bearing difficulty, Wheelchair user
Clinical narrative: Patient had gotten the flu shot on - Oct. 02-212. Next day running fever and had asthma attack went into respiratory failure and was brought back was air lifted to hospital and spent 17 days in hospital and suffered hypoxic brain injury due to lack of oxygen, during all of this.
Age: 5.0
Sex: M
Vaccine: FLU3, FLUX
Symptoms: Asthma, Brain injury, Condition aggravated, Electroencephalogram, Nuclear magnetic resonance imaging
Clinical narrative: Patient had gotten the flu shot on - Oct. 02-212. Next day running fever and had asthma attack went into respiratory failure and was brought back was air lifted to hospital and spent 17 days in hospital and suffered hypoxic brain injury due to lack of oxygen, during all of this.
Age: 5.0
Sex: M
Vaccine: FLU3, FLUX
Symptoms: Pyrexia, Respiratory failure, Resuscitation
Clinical narrative: Patient had gotten the flu shot on - Oct. 02-212. Next day running fever and had asthma attack went into respiratory failure and was brought back was air lifted to hospital and spent 17 days in hospital and suffered hypoxic brain injury due to lack of oxygen, during all of this.
Age: 9.0
Sex: F
Vaccine: HPV4, PPV, FLU3, HPV4, PPV, FLU3, HPV4, PPV
Symptoms: Lumbar puncture abnormal, Meningitis, Pyrexia, White blood cell count increased
Clinical narrative: Within 24 hours - headaches severe, temp 40, abd pain, inj site swelling erythema pain (R) arm (PNEUMOVAX 23). Pt went to ER and was sick enough to warrant CT head/Abd, LP and admission. Pt placed on Abx, acyclovir. Much improved next am. Cx neg at 72 hours pt stable and d/ced.
Age: 9.0
Sex: F
Vaccine: HPV4, PPV, FLU3, HPV4, PPV, FLU3, HPV4, PPV
Symptoms: Abdominal pain, Blood culture negative, Body temperature increased, C-reactive protein increased, CSF culture negative
Clinical narrative: Within 24 hours - headaches severe, temp 40, abd pain, inj site swelling erythema pain (R) arm (PNEUMOVAX 23). Pt went to ER and was sick enough to warrant CT head/Abd, LP and admission. Pt placed on Abx, acyclovir. Much improved next am. Cx neg at 72 hours pt stable and d/ced.
Age: 9.0
Sex: F
Vaccine: HPV4, PPV, FLU3, HPV4, PPV, FLU3, HPV4, PPV
Symptoms: CSF white blood cell count positive, Computerised tomogram abdomen, Computerised tomogram head, Culture urine negative, Headache
Clinical narrative: Within 24 hours - headaches severe, temp 40, abd pain, inj site swelling erythema pain (R) arm (PNEUMOVAX 23). Pt went to ER and was sick enough to warrant CT head/Abd, LP and admission. Pt placed on Abx, acyclovir. Much improved next am. Cx neg at 72 hours pt stable and d/ced.
Age: 9.0
Sex: F
Vaccine: HPV4, PPV, FLU3, HPV4, PPV, FLU3, HPV4, PPV
Symptoms: Human rhinovirus test positive, Injection site erythema, Injection site pain, Injection site swelling, Lumbar puncture
Clinical narrative: Within 24 hours - headaches severe, temp 40, abd pain, inj site swelling erythema pain (R) arm (PNEUMOVAX 23). Pt went to ER and was sick enough to warrant CT head/Abd, LP and admission. Pt placed on Abx, acyclovir. Much improved next am. Cx neg at 72 hours pt stable and d/ced.
Age: 9.0
Sex: F
Vaccine: HPV4, PPV, FLU3, HPV4, PPV, FLU3, HPV4, PPV
Symptoms: White blood cell count increased
Clinical narrative: Within 24 hours - headaches severe, temp 40, abd pain, inj site swelling erythema pain (R) arm (PNEUMOVAX 23). Pt went to ER and was sick enough to warrant CT head/Abd, LP and admission. Pt placed on Abx, acyclovir. Much improved next am. Cx neg at 72 hours pt stable and d/ced.
Age: 9.0
Sex: F
Vaccine: HPV4, PPV, FLU3, HPV4, PPV, FLU3, HPV4, PPV
Symptoms: Abdominal pain upper, Blood test abnormal, C-reactive protein increased, CSF white blood cell count, Headache
Clinical narrative: Within 24 hours - headaches severe, temp 40, abd pain, inj site swelling erythema pain (R) arm (PNEUMOVAX 23). Pt went to ER and was sick enough to warrant CT head/Abd, LP and admission. Pt placed on Abx, acyclovir. Much improved next am. Cx neg at 72 hours pt stable and d/ced.
Age: 9.0
Sex: F
Vaccine: HPV4, PPV, FLU3, HPV4, PPV, FLU3, HPV4, PPV
Symptoms: Influenza like illness, Lumbar puncture abnormal, Myalgia, Pyrexia, White blood cell count increased
Clinical narrative: Within 24 hours - headaches severe, temp 40, abd pain, inj site swelling erythema pain (R) arm (PNEUMOVAX 23). Pt went to ER and was sick enough to warrant CT head/Abd, LP and admission. Pt placed on Abx, acyclovir. Much improved next am. Cx neg at 72 hours pt stable and d/ced.
Age: 9.0
Sex: F
Vaccine: HPV4, PPV, FLU3, HPV4, PPV, FLU3, HPV4, PPV
Symptoms: Lumbar puncture abnormal, Meningitis, Pyrexia, White blood cell count increased
Clinical narrative: This case was reported by a healthcare professional and described the occurrence of elevated white blood cells in a 9-year-old female subject who was vaccinated with FLUARIX (GlaxoSmithKline), PNEUMO 23 (non-gsk) and GARDASIL. The subject's medical history included yeast infection. Concurrent medical conditions included asthma, environmental allergy and reflux (nos). Historic medications included DIFLUCAN. Concurrent medications included Loratadine, Albuterol, SINGULAIR and Ranitidine. On 6 November 2012 the subject received 1st dose of FLUARIX (.5 ml, intramuscular, left deltoid), 1st dose of PNEUMO 23 (unknown and 3rd dose of GARDASIL (unknown). On 07 November 2012, within 24 hours of vaccination with FLUARIX, GARDASIL and PNEUMO 23, the subject developed a fever. On 08 November 2012, two days after vaccinations, the subject required visit to an urgent care. The subject was sent to the local emergency department (ED) and admitted that same day. The healthcare professional reported a fever presented within 24 hours of vaccinations. The physician added that the subject also experienced headache, belly pain and muscle aches. The subject has an elevated white blood cell count that has increased from 8 to 22; she has white blood cell counts in her blood and spinal fluid. A spinal tap was performed in the ED. The physician stated "she was placed on intravenous antibiotic of Acyclovir and ROCEPHIN and other than the labs she looks wonderful today. However her labs look questionable for something other than just a typical flu type reaction. The subject's C - reactive protein (CRP) was very high, there were no RBCs. He stated that the labs were questionable for meningitis or encephalitis. The healthcare professional noted Merck has already been contacted and reported. The subject was hospitalised and the healthcare professional considered the events were life threatening and clinically significant (or requiring intervention). At the time of reporting the outcome of the fever, muscle pain, cerebrospinal fluid white cell count nos abnormal, 1 possible meningitis and possible encephalitis were unspecified. The elevated white blood cell count was unresolved and headache and abdominal pain had improved. The healthcare professional considered the events of elevated white blood cell count, headache, fever and abdominal pain were possibly related to vaccination with FLUARIX, PNEUMO 23 and GARDASIL.
Age: 9.0
Sex: F
Vaccine: HPV4, PPV, FLU3, HPV4, PPV, FLU3, HPV4, PPV
Symptoms: Abdominal pain, Blood culture negative, Body temperature increased, C-reactive protein increased, CSF culture negative
Clinical narrative: This case was reported by a healthcare professional and described the occurrence of elevated white blood cells in a 9-year-old female subject who was vaccinated with FLUARIX (GlaxoSmithKline), PNEUMO 23 (non-gsk) and GARDASIL. The subject's medical history included yeast infection. Concurrent medical conditions included asthma, environmental allergy and reflux (nos). Historic medications included DIFLUCAN. Concurrent medications included Loratadine, Albuterol, SINGULAIR and Ranitidine. On 6 November 2012 the subject received 1st dose of FLUARIX (.5 ml, intramuscular, left deltoid), 1st dose of PNEUMO 23 (unknown and 3rd dose of GARDASIL (unknown). On 07 November 2012, within 24 hours of vaccination with FLUARIX, GARDASIL and PNEUMO 23, the subject developed a fever. On 08 November 2012, two days after vaccinations, the subject required visit to an urgent care. The subject was sent to the local emergency department (ED) and admitted that same day. The healthcare professional reported a fever presented within 24 hours of vaccinations. The physician added that the subject also experienced headache, belly pain and muscle aches. The subject has an elevated white blood cell count that has increased from 8 to 22; she has white blood cell counts in her blood and spinal fluid. A spinal tap was performed in the ED. The physician stated "she was placed on intravenous antibiotic of Acyclovir and ROCEPHIN and other than the labs she looks wonderful today. However her labs look questionable for something other than just a typical flu type reaction. The subject's C - reactive protein (CRP) was very high, there were no RBCs. He stated that the labs were questionable for meningitis or encephalitis. The healthcare professional noted Merck has already been contacted and reported. The subject was hospitalised and the healthcare professional considered the events were life threatening and clinically significant (or requiring intervention). At the time of reporting the outcome of the fever, muscle pain, cerebrospinal fluid white cell count nos abnormal, 1 possible meningitis and possible encephalitis were unspecified. The elevated white blood cell count was unresolved and headache and abdominal pain had improved. The healthcare professional considered the events of elevated white blood cell count, headache, fever and abdominal pain were possibly related to vaccination with FLUARIX, PNEUMO 23 and GARDASIL.
Age: 9.0
Sex: F
Vaccine: HPV4, PPV, FLU3, HPV4, PPV, FLU3, HPV4, PPV
Symptoms: CSF white blood cell count positive, Computerised tomogram abdomen, Computerised tomogram head, Culture urine negative, Headache
Clinical narrative: This case was reported by a healthcare professional and described the occurrence of elevated white blood cells in a 9-year-old female subject who was vaccinated with FLUARIX (GlaxoSmithKline), PNEUMO 23 (non-gsk) and GARDASIL. The subject's medical history included yeast infection. Concurrent medical conditions included asthma, environmental allergy and reflux (nos). Historic medications included DIFLUCAN. Concurrent medications included Loratadine, Albuterol, SINGULAIR and Ranitidine. On 6 November 2012 the subject received 1st dose of FLUARIX (.5 ml, intramuscular, left deltoid), 1st dose of PNEUMO 23 (unknown and 3rd dose of GARDASIL (unknown). On 07 November 2012, within 24 hours of vaccination with FLUARIX, GARDASIL and PNEUMO 23, the subject developed a fever. On 08 November 2012, two days after vaccinations, the subject required visit to an urgent care. The subject was sent to the local emergency department (ED) and admitted that same day. The healthcare professional reported a fever presented within 24 hours of vaccinations. The physician added that the subject also experienced headache, belly pain and muscle aches. The subject has an elevated white blood cell count that has increased from 8 to 22; she has white blood cell counts in her blood and spinal fluid. A spinal tap was performed in the ED. The physician stated "she was placed on intravenous antibiotic of Acyclovir and ROCEPHIN and other than the labs she looks wonderful today. However her labs look questionable for something other than just a typical flu type reaction. The subject's C - reactive protein (CRP) was very high, there were no RBCs. He stated that the labs were questionable for meningitis or encephalitis. The healthcare professional noted Merck has already been contacted and reported. The subject was hospitalised and the healthcare professional considered the events were life threatening and clinically significant (or requiring intervention). At the time of reporting the outcome of the fever, muscle pain, cerebrospinal fluid white cell count nos abnormal, 1 possible meningitis and possible encephalitis were unspecified. The elevated white blood cell count was unresolved and headache and abdominal pain had improved. The healthcare professional considered the events of elevated white blood cell count, headache, fever and abdominal pain were possibly related to vaccination with FLUARIX, PNEUMO 23 and GARDASIL.
Age: 9.0
Sex: F
Vaccine: HPV4, PPV, FLU3, HPV4, PPV, FLU3, HPV4, PPV
Symptoms: Human rhinovirus test positive, Injection site erythema, Injection site pain, Injection site swelling, Lumbar puncture
Clinical narrative: This case was reported by a healthcare professional and described the occurrence of elevated white blood cells in a 9-year-old female subject who was vaccinated with FLUARIX (GlaxoSmithKline), PNEUMO 23 (non-gsk) and GARDASIL. The subject's medical history included yeast infection. Concurrent medical conditions included asthma, environmental allergy and reflux (nos). Historic medications included DIFLUCAN. Concurrent medications included Loratadine, Albuterol, SINGULAIR and Ranitidine. On 6 November 2012 the subject received 1st dose of FLUARIX (.5 ml, intramuscular, left deltoid), 1st dose of PNEUMO 23 (unknown and 3rd dose of GARDASIL (unknown). On 07 November 2012, within 24 hours of vaccination with FLUARIX, GARDASIL and PNEUMO 23, the subject developed a fever. On 08 November 2012, two days after vaccinations, the subject required visit to an urgent care. The subject was sent to the local emergency department (ED) and admitted that same day. The healthcare professional reported a fever presented within 24 hours of vaccinations. The physician added that the subject also experienced headache, belly pain and muscle aches. The subject has an elevated white blood cell count that has increased from 8 to 22; she has white blood cell counts in her blood and spinal fluid. A spinal tap was performed in the ED. The physician stated "she was placed on intravenous antibiotic of Acyclovir and ROCEPHIN and other than the labs she looks wonderful today. However her labs look questionable for something other than just a typical flu type reaction. The subject's C - reactive protein (CRP) was very high, there were no RBCs. He stated that the labs were questionable for meningitis or encephalitis. The healthcare professional noted Merck has already been contacted and reported. The subject was hospitalised and the healthcare professional considered the events were life threatening and clinically significant (or requiring intervention). At the time of reporting the outcome of the fever, muscle pain, cerebrospinal fluid white cell count nos abnormal, 1 possible meningitis and possible encephalitis were unspecified. The elevated white blood cell count was unresolved and headache and abdominal pain had improved. The healthcare professional considered the events of elevated white blood cell count, headache, fever and abdominal pain were possibly related to vaccination with FLUARIX, PNEUMO 23 and GARDASIL.
Age: 9.0
Sex: F
Vaccine: HPV4, PPV, FLU3, HPV4, PPV, FLU3, HPV4, PPV
Symptoms: White blood cell count increased
Clinical narrative: This case was reported by a healthcare professional and described the occurrence of elevated white blood cells in a 9-year-old female subject who was vaccinated with FLUARIX (GlaxoSmithKline), PNEUMO 23 (non-gsk) and GARDASIL. The subject's medical history included yeast infection. Concurrent medical conditions included asthma, environmental allergy and reflux (nos). Historic medications included DIFLUCAN. Concurrent medications included Loratadine, Albuterol, SINGULAIR and Ranitidine. On 6 November 2012 the subject received 1st dose of FLUARIX (.5 ml, intramuscular, left deltoid), 1st dose of PNEUMO 23 (unknown and 3rd dose of GARDASIL (unknown). On 07 November 2012, within 24 hours of vaccination with FLUARIX, GARDASIL and PNEUMO 23, the subject developed a fever. On 08 November 2012, two days after vaccinations, the subject required visit to an urgent care. The subject was sent to the local emergency department (ED) and admitted that same day. The healthcare professional reported a fever presented within 24 hours of vaccinations. The physician added that the subject also experienced headache, belly pain and muscle aches. The subject has an elevated white blood cell count that has increased from 8 to 22; she has white blood cell counts in her blood and spinal fluid. A spinal tap was performed in the ED. The physician stated "she was placed on intravenous antibiotic of Acyclovir and ROCEPHIN and other than the labs she looks wonderful today. However her labs look questionable for something other than just a typical flu type reaction. The subject's C - reactive protein (CRP) was very high, there were no RBCs. He stated that the labs were questionable for meningitis or encephalitis. The healthcare professional noted Merck has already been contacted and reported. The subject was hospitalised and the healthcare professional considered the events were life threatening and clinically significant (or requiring intervention). At the time of reporting the outcome of the fever, muscle pain, cerebrospinal fluid white cell count nos abnormal, 1 possible meningitis and possible encephalitis were unspecified. The elevated white blood cell count was unresolved and headache and abdominal pain had improved. The healthcare professional considered the events of elevated white blood cell count, headache, fever and abdominal pain were possibly related to vaccination with FLUARIX, PNEUMO 23 and GARDASIL.